[11C2-11C2];[11E5-11E5];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
11C2;11E5
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.WH5}BSC545 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC545 predicted from the Release 5 genomic coordinates of the progenitor P{XP}d05563 and PBac{WH}mewf07434 transposable element insertion sites are 11C2;11E5.